An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Tempus AI, Inc. in Chicago seeks a Senior Director, Functional Genomics & Organoid Systems Biology to lead its PDO biology platform, driving wet-lab strategy and integrating with computational data to uncover therapeutic opportunities.
You will build and mentor a multidisciplinary team, oversee CRISPR and drug screening in patient-derived organoids, partner with clinical and data science teams, and shape the scientific vision for translational oncology.
Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time. We are seeking an exceptional Senior Director, Functional Genomics & Organoid Systems Biology to lead and expand our patient-derived organoid (PDO) biology platform. This leader will drive the wet lab component of our systems biology team, and will help define how this experimental layer will combine with computational approaches and the massive multimodal Tempus data layer to unlock new biological insights. This leader will oversee a multidisciplinary team of scientists and research associates responsible for executing large-scale functional screens—including CRISPR-based genetic perturbation screens, drug sensitivity screens, single-cell and spatial technologies, and combination therapy studies—in clinically annotated patient-derived organoid models. The successful candidate will define and drive the scientific vision for leveraging PDOs to validate hypotheses generated from Tempus' unique real-world clinico-genomic data assets. Working closely with computational scientists, machine learning researchers, translational scientists, and clinical teams, this individual will establish an integrated discovery engine that translates patient data into experimentally validated therapeutic opportunities. This is a highly visible leadership role that combines scientific strategy, organizational leadership, platform development, and translational research to identify novel targets, biomarkers, and therapeutic strategies for cancer patients. This position is based in Tempus’ Chicago lab: hybrid or remote candidates will not be considered.
CHI: $190,000 - $270,000
The expected salary range above is applicable if the role is performed from Illinois and may vary for other locations (California, Colorado, New York).
Actual salary may vary based on qualifications and experience.
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Tempus was founded in August of 2015 by Eric Lefkofsky, after his wife was diagnosed with Breast Cancer. Shortly after he founded the company in an effort to bring the power of technology and artificial intelligence to cancer care, he convinced Ryan Fukushima to join as the company’s first employee. Ryan and Eric began assembling a world class team, focused on building the first version of a platform capable of ingesting real time healthcare data in an effort to personalize diagnostics.
We built the platform for oncology and have expanded it to neuropsychiatry, cardiology, infectious disease (through COVID), and radiology. Despite our rapid growth, our mission remains the same—to help make sure patients are on the right drug at the right time, so they can live longer and healthier lives. We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems mankindhasever faced. Headon.